|
| |
|
- Code on Interactions with Healthcare Professionals
Ethical relationships with healthcare professionals are critical to the pharmaceutical industry's mission of helping patients by developing and marketing new medicines.
- Report: More than 400 Biotechnology Medicines in Testing
A new report found 418 medicines and vaccines – developed through biotechnology – now being tested to treat more than 100 diseases.
- New Facts on the Value of Medicines
New medicines help avert surgeries and trips to the ER, prevent disability, and improve quality of life for patients everywhere. The benefits ripple beyond individual patients to society in general. The charts in this book illustrate the diverse and far-reaching benefits of prescription medicines.
- State Bioscience Community Launches Newsletter
The State Bioscience Community Launches Volume 1 Issue 1 of their eNewsletter.
- Pharmaceutical Companies Leading the Way in Corporate Philanthropy
Did you know that the pharmaceutical research industry leads the nation in corporate philanthropy? Thirty-four cents of every dollar donated to philanthropic causes by major U.S. corporations is donated by pharmaceutical research companies, according to the Chronicles of Philanthropy.
- Report: A Primer on Price Controls
According to a new report, politicians are once again flirting with price controls. But price controls actually hurt low-income people because they keep prices artificially high, plus they stifle competition and destroy innovation.
- Report: High Blood Pressure Treatment Helps Reduce Risk for West Virginia Seniors
A new report shows that active treatment for hypertension, and increased access to medicines through the Medicare prescription drug plan, may help seniors avoid serious events like stroke.
- Medicare’s Prevention and Drug Benefits Will Work Together to Keep Beneficiaries Healthy
The new preventive benefits go hand in hand with the Medicare prescription drug benefit and will help seniors optimize their care.
- Department of Health & Human Services – Competition, Innovation and Pricing for Modern Medicines
Government actions affect prices, prices affect investment, investment affects innovation, and innovation affects health. The more free competition there is in the pharmaceutical and medical device market, the more innovation the world will enjoy.
- PhRMA CEO Billy Tauzin on Access to Medicine in West Virginia
West Virginians are right to review the issues surrounding the access and affordability of prescription medicines. You should know these facts.
- Report: New CMS Data: Rx Drug Spending Only 10 Cents of Healthcare Dollar
A new report by the Centers for Medicare and Medicaid Services (CMS) confirms that of every healthcare dollar spent in the U.S., only about 10 cents is spent on prescription drugs.
- Report: More Than 900 Medicines Are in Testing To Combat Diseases of Aging
A new survey finds more than 900 medicines in development for diseases of aging, including 146 for heart disease and stroke, 399 for cancer, and 373 for such debilitating diseases as Alzheimer’s, diabetes, and osteoporosis.
- Helping One Patient at a Time – A Report on West Virginias Partnership for Prescription Assistance Program
A report on the successes, challenges and opportunities in the first seven months of West Virginia’s Partnership for Prescription Assistance (PPA).
- Tough Questions, Straight Answers – A Discussion of Today’s Pharmaceutical Issues
This brochure highlights some tough questions that have been asked about pharmaceutical spending, presenting answers rooted in research, analysis, and facts.
- Report: A Decade of Innovation
A study examining the past decade’s innovations in treatments for rheumatoid arthritis (RA), HIV/AIDS, Parkinson’s disease, Alzheimer’s disease, schizophrenia, diabetes, high blood pressure, and high blood cholesterol.
- Report: The Value of Investment in Healthcare
A recent study authored by MEDTAP International and released by a broad coalition of health care groups examining healthcare advances.
- More Than 400 New Medicines Now in Development For Women; 62 for Breast Cancer Alone
Pharmaceutical researchers are developing 446 medicines for diseases that disproportionately affect American women. This recent report by PhRMA details potential new medicines in the pipeline for women (either in clinical trials or awaiting approval at the Food and Drug Administration).
- What Goes Into the Cost of Prescription Drugs? …And Other Questions About Your Medicines
The question of what goes into the cost of prescription drugs is today at the heart of the healthcare debate. As in any debate, it is important that the public be well informed. Here, we present facts to try to answer some of these questions about the cost of medicines.
- Guaranteed Future Pain and Suffering: The Recent Research on Drug Price Controls by Derek Hunter, Heritage Foundation, November 3, 2005.
Recent research shows that price controls would lead to less research and development in the pharmaceutical industry, fewer new prescription drugs, and the reduced availability of prescription drugs.
|
|
|
